Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

1447 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Bulk Anti-­Human CD195 (HEK/­1/­85a/­7a) Antibody (CCR5) -­ Ultra-­Low Endotoxin Download product datasheet Antibody HEK/1/85a/7a Hu FC, ICC Rat ICH1172UL-25MG

IchorBio
25 mg Login
Compare
Bulk Anti-­Human CD195 (HEK/­1/­85a/­7a) Antibody (CCR5) -­ Ultra-­Low Endotoxin Download product datasheet Antibody HEK/1/85a/7a Hu FC, ICC Rat ICH1172UL-50MG

IchorBio
50 mg Login
Compare
Bulk Anti-­Human CD195 (HEK/­1/­85a/­7a) Antibody (CCR5) -­ Ultra-­Low Endotoxin Download product datasheet Antibody HEK/1/85a/7a Hu FC, ICC Rat ICH1172UL-100MG

IchorBio
100 mg Login
Compare
Tisagenlecleucel Biosimilar -­ Research Grade Hu FA CHO cells ICH5928-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Tisagenlecleucel Biosimilar -­ Research Grade Hu FA CHO cells ICH5928-1mg

IchorBio
1 mg Login
Compare
Tisagenlecleucel Biosimilar -­ Research Grade Hu FA CHO cells ICH5928-25mg

IchorBio
25 mg Login
Compare
Tisagenlecleucel Biosimilar -­ Research Grade Hu FA CHO cells ICH5928-50mg

IchorBio
50 mg Login
Compare
Tisagenlecleucel Biosimilar -­ Research Grade Hu FA CHO cells ICH5928-5mg

IchorBio
5 mg Login
Compare
Tomuzotuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5933-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Tomuzotuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5933-1mg

IchorBio
1 mg Login
Compare
Tomuzotuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5933-25mg

IchorBio
25 mg Login
Compare
Tomuzotuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5933-50mg

IchorBio
50 mg Login
Compare
Tomuzotuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5933-5mg

IchorBio
5 mg Login
Compare
Tositumomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5937-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Tositumomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5937-1mg

IchorBio
1 mg Login
Compare
Tositumomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5937-25mg

IchorBio
25 mg Login
Compare
Tositumomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5937-50mg

IchorBio
50 mg Login
Compare
Tositumomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5937-5mg

IchorBio
5 mg Login
Compare
Tregalizumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5942-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Tregalizumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5942-1mg

IchorBio
1 mg Login
Compare
Tregalizumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5942-25mg

IchorBio
25 mg Login
Compare
Tregalizumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5942-50mg

IchorBio
50 mg Login
Compare
Tregalizumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5942-5mg

IchorBio
5 mg Login
Compare
Ulocuplumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5954-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Ulocuplumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5954-1mg

IchorBio
1 mg Login
Compare
Name Price
Bulk Anti-­Human CD195 (HEK/­1/­85a/­7a) Antibody (CCR5) -­ Ultra-­Low Endotoxin Login
Type Antibody
Clone HEK/1/85a/7a
Specific against Hu
Appl. FC, ICC
Host Rat
Item no.
Amount 25 mg
Available
Bulk Anti-­Human CD195 (HEK/­1/­85a/­7a) Antibody (CCR5) -­ Ultra-­Low Endotoxin Login
Type Antibody
Clone HEK/1/85a/7a
Specific against Hu
Appl. FC, ICC
Host Rat
Item no.
Amount 50 mg
Available
Bulk Anti-­Human CD195 (HEK/­1/­85a/­7a) Antibody (CCR5) -­ Ultra-­Low Endotoxin Login
Type Antibody
Clone HEK/1/85a/7a
Specific against Hu
Appl. FC, ICC
Host Rat
Item no.
Amount 100 mg
Available
Tisagenlecleucel Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Tisagenlecleucel Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Tisagenlecleucel Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Tisagenlecleucel Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Tisagenlecleucel Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Tomuzotuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Tomuzotuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Tomuzotuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Tomuzotuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Tomuzotuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Tositumomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Tositumomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Tositumomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Tositumomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Tositumomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Tregalizumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Tregalizumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Tregalizumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Tregalizumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Tregalizumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Ulocuplumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Ulocuplumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available

1447 Item(s)

per page